Stay updated on Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows Revision: v3.4.2 and the previous funding-status notice and Revision: v3.4.1 banner were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page displays a government funding status notice and updates the UI version label from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary toggle added to improve term explanations, and the page now includes a QC-related label ('Last Update Submitted that Met QC Criteria'), a capitalization update for 'No FEAR Act Data', and a new revision tag ('Revision: v3.4.0').SummaryDifference0.2%

- Check64 days agoChange DetectedAdded a Locations section listing participating states and sites (Alabama, Arizona, California, Colorado, Florida, Illinois, Louisiana, Massachusetts, Minnesota, Missouri, Nevada, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Utah, Washington). Updated to Revision: v3.3.3.SummaryDifference2%

- Check85 days agoChange DetectedFooter now shows Revision: v3.3.2 instead of v3.3.1. No study content or navigation changes are visible.SummaryDifference0.0%

- Check92 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.